-
Kenya's economy faces climate change risks: World Bank
-
Troubled waters: Thai fishermen marooned by rising fuel costs
-
Nigerian president meets royals on 'historic' UK state visit
-
Why convoys cannot fully protect oil tankers from Iran attacks
-
Oil wavers, stocks rise as attention turns to US Fed
-
China tech giant Tencent bets on AI agents
-
Israelis shelter with pets from threat of Iran missiles
-
Deadly strikes across Mideast as Iran vows revenge on slain security chief
-
Brussels to unveil 'EU Inc' pan-European company status
-
Brazil starts to restrict minors' access to social media
-
US Fed expected to hold rates steady as Iran war's shockwaves ripple
-
Oscars audience drops, viewing figures show
-
Nvidia says restarting production of China-bound chips
-
US airlines still see strong demand as jet fuel worries loom
-
Milei blasts Iran on anniversary of attack on Israeli embassy
-
Leftist New York mayor under pressure on Irish unity question
-
Iran vets friendly ships for Hormuz passage: trackers
-
Ships in Gulf risk shortages on board, industry warns
-
New particle discovered by Large Hadron Collider
-
US Fed expected to keep rates steady as Iran war impact looms
-
Kerr 'frustrated' at six-figure sum owed to him by Johnson's failed Grand Slam Track
-
Oil prices climb as fresh strikes target infrastructure
-
Belgian diplomat ordered to stand trial over 1961 Congo leader murder
-
War threatens Gulf's dugongs, turtles and birds
-
Germany targets oil firms to prevent wartime price gouging
-
EU to help reopen blocked oil pipeline in Ukraine
-
Cash handouts, fare hikes as Philippines battles soaring fuel costs
-
Indonesia weighs response to price pressures from Middle East war
-
In Hollywood, AI's no match for creativity, say top executives
-
Nvidia chief expects revenue of $1 trillion through 2027
-
Nvidia making AI module for outer space
-
Migrant workers bear brunt of Iran attacks in Gulf
-
Trump vows to 'take' Cuba as island reels from oil embargo
-
Equities rise on oil easing, with focus on Iran war and central banks
-
Nvidia rides 'claw' craze with AI agent platform
-
Damaged Russian tanker has 700 tonnes of fuel on board: Moscow
-
Talks towards international panel to tackle 'inequality emergency' begin at UN
-
EU talks energy as oil price soars
-
Swiss government rejects proposal to limit immigration
-
Ingredients of life discovered in Ryugu asteroid samples
-
Why Iranian drones are hard to stop
-
France threatens to block funds for India over climate inaction
-
"So proud": Irish hometown hails Oscar winner Jessie Buckley
-
European bank battle heats up as UniCredit swoops for Commerzbank
-
Italian bank UniCredit makes bid for Germany's Commerzbank
-
AI to drive growth despite geopolitics, Taiwan's Foxconn says
-
Filipinas seek abortions online in largely Catholic nation
-
'One Battle After Another' wins best picture Oscar
-
South Koreans bask in Oscars triumph for 'KPop Demon Hunters'
-
'One Battle After Another' dominates Oscars
'Love hormone'? Not so fast, new study suggests
The "love hormone" oxytocin has long been thought key to behaviours including pairing up with a partner and nurturing offspring, but a new study in prairie voles is raising doubts.
The research found that voles bred to lack functioning receptors for oxytocin were still able to form strong pairs, produce young and nurse -- all behaviours previously believed to depend on the hormone.
Prairie voles are one of the few mammals that mate for life, and are often used to study social behaviours like pair-forming in animals.
In past studies, voles given drugs that stopped oxytocin being processed no longer formed pairs, and mothers failed to produce milk for their young.
Psychiatrist Devanand Manoli and neurobiologist Nirao Shah produced genetically altered prairie voles without working oxytocin receptors, and then observed how the mutant male and female voles behaved.
To their shock, the mutant voles appeared to have no difficulty pairing up with non-genetically altered partners, and mutant females could still deliver and nurse young, unlike those in the drug-driven studies.
"We were certainly surprised," said Manoli, an assistant professor at the University of California, San Francisco.
The results suggest that oxytocin is not the main, or only, driver of activities like partnering or nursing, he said.
"What the genetics reveals is that there isn't a 'single point of failure' for behaviours that are so critical to the survival of the species," he told AFP.
- 'Very complex behaviours' -
That didn't mean there were no differences, however.
Some male mutant voles that paired with ordinary female partners didn't show the aggression towards interloping females that would normally be expected.
And while mutant females produced and nursed litters, some had fewer pups per litter than their counterparts, and fewer of their offspring survived to weaning, the paper published Friday in the journal Neuron explains.
Pups born to mutant mothers also tended to weigh less, suggesting that they were not able to nurse as effectively.
The study only involved pairing of mutant voles with "wild-type" partners, and the researchers said pairings with two mutant partners could produce different results.
Still, as a whole, the findings suggest a different picture of oxytocin's role in several important behaviours.
That could be because animals bred without the receptors developed "other compensatory pathways" that helped them pair up and nurse, said Shah, a professor at Stanford University.
But the researchers suggest it likely means oxytocin is only part of a set of genetic factors that control social behaviour.
"What I think our studies reveal is that there are multiple pathways that regulate these very complex behaviours," said Manoli.
Oxytocin has sometimes been suggested as a way to treat attachment disorders and other neuropsychiatric issues, but there is little settled science on how effective it is.
Now the researchers hope to investigate what other hormones and receptors may be involved in behaviours like pairing and nursing.
"These other pathways might serve as new therapeutic targets," Manoli said.
Ng.A.Adebayo--CPN